Glecaprevir + Pibrentasvir

Kathryn Dzintars, Pharm.D., BCPS
Glecaprevir + Pibrentasvir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of adult patients with chronic HCV infection (genotypes 1, 2, 3, 4, 5, or 6) without cirrhosis or compensated cirrhosis (Child-Pugh A).
  • Treatment of adult patients with HCV Genotype 1 infection previously treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of adult patients with chronic HCV infection (genotypes 1, 2, 3, 4, 5, or 6) without cirrhosis or compensated cirrhosis (Child-Pugh A).
  • Treatment of adult patients with HCV Genotype 1 infection previously treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: July 10, 2018